Responding to the COVID-19 Pandemic

Abstract

Though the company InnAccel Technologies Pvt. Ltd. started as an incubator in 2012, it combined its operations with Coeo Labs and Sattva Medtech, the former incubates, in 2019, thereby creating a single entity with a portfolio of innovative and life-saving products in the field of medical technology. It developed three innovative products, namely VapCare, Fetal Lite, and SAANS. With growing COVID-19 cases worldwide, there was a dire need for respiratory support, which could be in the form of invasive and non-invasive ventilation systems. Hence, InnAccel launched Saans Pro, which is a non-invasive ventilation system, an infrastructure independent technology for COVID-19 patients in ICU. It could be used to treat patients who are not stressed and have no other organ failure. The case presents the three main challenges faced by firms: commercialization, consumer acceptance of its products (Indian) in domestic and international markets, and dilemma of whether to venture into the international markets.